France’s Novadiscovery has raised €2.5m ($3.03m) in a series A2 financing from Sanofi to further develop its proprietary JINKO in silico or virtual clinical trial simulation platform and expand into the US market.
Nova will collaborate with Sanofi to develop a COVID-19 disease model to support the latter’s efforts in tackling the pandemic...